ES2174107T3 - Preparaciones combinadas framaceuticas que contienen eritropoyetina y preparaciones de hierro. - Google Patents
Preparaciones combinadas framaceuticas que contienen eritropoyetina y preparaciones de hierro.Info
- Publication number
- ES2174107T3 ES2174107T3 ES96932503T ES96932503T ES2174107T3 ES 2174107 T3 ES2174107 T3 ES 2174107T3 ES 96932503 T ES96932503 T ES 96932503T ES 96932503 T ES96932503 T ES 96932503T ES 2174107 T3 ES2174107 T3 ES 2174107T3
- Authority
- ES
- Spain
- Prior art keywords
- preparations
- combined
- framaceutical
- erythropoyetin
- iron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 229940082629 iron antianemic preparations Drugs 0.000 title 1
- 102000003951 Erythropoietin Human genes 0.000 abstract 2
- 108090000394 Erythropoietin Proteins 0.000 abstract 2
- 229940105423 erythropoietin Drugs 0.000 abstract 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 2
- 208000007502 anemia Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
EL OBJETO DE LA PRESENTE INVENCION ES UN PREPARADO COMBINADO A BASE DE 2.000 - 7.000 U DE ERITROPOIETIN RECOMBINANTE HUMANO (EPO) Y 5 - 20 MG DE UN COMPLEJO DE FE(III), PUDIENDO PRESENTARSE EL RHEPO Y EL COMPLEJO DE FE(III) EN FORMAS DE ADMINISTRACION SEPARADAS O EN UNA FORMA UNIFICADA. EL PREPARADO FARMACEUTICO SIRVE PARA EL TRATAMIENTO DE ANEMIAS O DE PACIENTES SOMETIDOS A HEMODIALISIS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19535571A DE19535571A1 (de) | 1995-09-14 | 1995-09-14 | Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2174107T3 true ES2174107T3 (es) | 2002-11-01 |
Family
ID=7773098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96932503T Expired - Lifetime ES2174107T3 (es) | 1995-09-14 | 1996-09-12 | Preparaciones combinadas framaceuticas que contienen eritropoyetina y preparaciones de hierro. |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US6333306B1 (es) |
| EP (1) | EP0851762B1 (es) |
| JP (1) | JP4783482B2 (es) |
| KR (1) | KR100350761B1 (es) |
| CN (1) | CN1133463C (es) |
| AT (1) | ATE216256T1 (es) |
| AU (1) | AU724623B2 (es) |
| BR (1) | BR9609971A (es) |
| CA (1) | CA2231192C (es) |
| CZ (1) | CZ291427B6 (es) |
| DE (3) | DE19535571A1 (es) |
| DK (1) | DK0851762T3 (es) |
| EE (1) | EE03856B1 (es) |
| ES (1) | ES2174107T3 (es) |
| HU (1) | HU225363B1 (es) |
| IL (2) | IL123640A0 (es) |
| MX (1) | MX9801922A (es) |
| NO (1) | NO329908B1 (es) |
| NZ (1) | NZ319132A (es) |
| PL (1) | PL186776B1 (es) |
| PT (1) | PT851762E (es) |
| SK (1) | SK285796B6 (es) |
| TR (1) | TR199800472T1 (es) |
| UA (1) | UA57713C2 (es) |
| WO (1) | WO1997009996A1 (es) |
| ZA (1) | ZA967732B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU726801B2 (en) * | 1997-03-18 | 2000-11-23 | Roche Diagnostics Gmbh | Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| EP0885613A1 (de) | 1997-06-21 | 1998-12-23 | Roche Diagnostics GmbH | Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin |
| DE19734293A1 (de) * | 1997-08-08 | 1999-02-11 | Boehringer Mannheim Gmbh | Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen |
| US7304150B1 (en) | 1998-10-23 | 2007-12-04 | Amgen Inc. | Methods and compositions for the prevention and treatment of anemia |
| DK1813624T3 (da) * | 1998-10-23 | 2010-11-22 | Amgen Inc | Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi |
| CN100528235C (zh) | 2000-12-20 | 2009-08-19 | 霍夫曼-拉罗奇有限公司 | 红细胞生成素共轭物 |
| EP1909106B1 (en) * | 2001-09-14 | 2013-01-02 | F. Hoffmann-La Roche AG | Differential diagnosis of disorders of iron metabolism by means of four parameters and recommendations for the treatment of these disorders of iron metabolism |
| US6930086B2 (en) | 2001-09-25 | 2005-08-16 | Hoffmann-La Roche Inc. | Diglycosylated erythropoietin |
| US7300915B2 (en) * | 2002-06-05 | 2007-11-27 | The Regents Of The University Of California | Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain |
| US7459435B2 (en) * | 2002-08-29 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| US7459436B2 (en) | 2002-11-22 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| US7964568B2 (en) * | 2003-05-30 | 2011-06-21 | Chromaceutical Advanced Technologies, Inc. | Synthesis of high molecular weight iron-saccharidic complexes |
| US7772182B2 (en) * | 2004-08-05 | 2010-08-10 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists |
| US7586589B2 (en) * | 2005-09-24 | 2009-09-08 | Beckman Coulter, Inc. | Methods of determination of responsiveness to erythropoietin treatment |
| KR20090046923A (ko) | 2006-08-04 | 2009-05-11 | 프로롱 파마슈티컬스, 인크. | 수식된 에리스로포이에틴 |
| CL2008002053A1 (es) | 2007-07-17 | 2009-05-22 | Hoffmann La Roche | Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion. |
| AR067536A1 (es) * | 2007-07-17 | 2009-10-14 | Hoffmann La Roche | Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea |
| AU2014278543B2 (en) * | 2013-06-13 | 2019-11-14 | Akebia Therapeutics, Inc. | Compositions and methods for treating anemia |
| CN115819494A (zh) | 2015-11-23 | 2023-03-21 | 百时美施贵宝公司 | 用于蛋白质聚乙二醇化的添加剂体系 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6039681B2 (ja) * | 1976-01-01 | 1985-09-07 | 日本臓器製薬株式会社 | デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤 |
| IL77081A (en) | 1984-12-04 | 1999-10-28 | Genetics Inst | AND sequence encoding human erythropoietin, a process for its preparation and a pharmacological preparation of human erythropoietin |
| JPS6231A (ja) * | 1985-02-06 | 1987-01-06 | Chugai Pharmaceut Co Ltd | 腎性貧血治療剤 |
| US4745099A (en) * | 1985-02-06 | 1988-05-17 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition for the treatment of the anemia of malignant tumors |
| KR880012235A (ko) * | 1987-04-10 | 1988-11-26 | 벤자민 에프.람버트 | 정상 포유동물의 헤마토크릿을 증가시키는 방법 |
-
1995
- 1995-09-14 DE DE19535571A patent/DE19535571A1/de not_active Withdrawn
-
1996
- 1996-09-12 PT PT96932503T patent/PT851762E/pt unknown
- 1996-09-12 EP EP96932503A patent/EP0851762B1/de not_active Expired - Lifetime
- 1996-09-12 IL IL12364096A patent/IL123640A0/xx active IP Right Grant
- 1996-09-12 US US09/029,859 patent/US6333306B1/en not_active Expired - Lifetime
- 1996-09-12 DE DE19680768T patent/DE19680768D2/de not_active Expired - Lifetime
- 1996-09-12 JP JP51166197A patent/JP4783482B2/ja not_active Expired - Lifetime
- 1996-09-12 AU AU71282/96A patent/AU724623B2/en not_active Expired
- 1996-09-12 AT AT96932503T patent/ATE216256T1/de active
- 1996-09-12 PL PL96325640A patent/PL186776B1/pl unknown
- 1996-09-12 CA CA002231192A patent/CA2231192C/en not_active Expired - Lifetime
- 1996-09-12 NZ NZ319132A patent/NZ319132A/en not_active IP Right Cessation
- 1996-09-12 DE DE59609099T patent/DE59609099D1/de not_active Expired - Lifetime
- 1996-09-12 CN CNB961982845A patent/CN1133463C/zh not_active Expired - Lifetime
- 1996-09-12 ES ES96932503T patent/ES2174107T3/es not_active Expired - Lifetime
- 1996-09-12 TR TR1998/00472T patent/TR199800472T1/xx unknown
- 1996-09-12 KR KR10-1998-0701860A patent/KR100350761B1/ko not_active IP Right Cessation
- 1996-09-12 SK SK327-98A patent/SK285796B6/sk not_active IP Right Cessation
- 1996-09-12 HU HU9900357A patent/HU225363B1/hu unknown
- 1996-09-12 BR BR9609971-2A patent/BR9609971A/pt not_active Application Discontinuation
- 1996-09-12 EE EE9800066A patent/EE03856B1/xx unknown
- 1996-09-12 CZ CZ1998726A patent/CZ291427B6/cs not_active IP Right Cessation
- 1996-09-12 DK DK96932503T patent/DK0851762T3/da active
- 1996-09-12 WO PCT/EP1996/003997 patent/WO1997009996A1/de active IP Right Grant
- 1996-09-12 MX MX9801922A patent/MX9801922A/es unknown
- 1996-09-13 ZA ZA9607732A patent/ZA967732B/xx unknown
- 1996-12-09 UA UA98041874A patent/UA57713C2/uk unknown
-
1998
- 1998-03-11 IL IL123640A patent/IL123640A/en not_active IP Right Cessation
- 1998-03-13 NO NO19981136A patent/NO329908B1/no not_active IP Right Cessation
-
2001
- 2001-10-29 US US09/984,268 patent/US20020049161A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2174107T3 (es) | Preparaciones combinadas framaceuticas que contienen eritropoyetina y preparaciones de hierro. | |
| DE59811158D1 (de) | Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen | |
| EP0494972A4 (en) | Effervescent dosage form and method of administering same | |
| DE60115029D1 (de) | Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate | |
| ATE306931T1 (de) | Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer | |
| ATE401892T1 (de) | Verwendung von pharmazeutischen zubereitungen enthaltend oxcarbazepin im nüchternzustand | |
| HUP0400689A2 (hu) | ABCA-1 szint-emelő vegyületek | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| HUP0001266A2 (hu) | Nagyon kis oldhatóságú platinakomplexek lipidkomplexei és liposzómái | |
| ES2037086T3 (es) | Procedimiento para preparar formulaciones farmaceuticas. | |
| HUP0003713A2 (hu) | Króm és biotin tartalmú gyógyászati készítmény II típusú diabétesz kezelésére | |
| ATE272405T1 (de) | Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine | |
| NO943288L (no) | Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer | |
| TR200000455T2 (tr) | Alzheimer hastalığının tedavisinde fankinonun kullanılması. | |
| FI982689A0 (fi) | 2-fenyyli-1,2-bentsoisoselenatsol-3(2H)-onin käyttö Alzheimerin taudin käsittelyyn tarkoiettujen farmaseuttisten valmisteiden valmistukseen | |
| ES2180958T3 (es) | Preparaciones farmaceuticas combinadas que contienen preparaciones de eritropoyetina y de hierro. | |
| AU3862997A (en) | Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof | |
| Bouman et al. | Recurrent hyponatremia associated with sertraline and lofepramine. | |
| HUP0100542A2 (hu) | Progesztogént és anti-progesztogént tartalmazó kit, eljárás előállítására és a vegyületek alkalmazása fogamzásgátló szer előállítására | |
| MY114218A (en) | The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations. | |
| CA2329665A1 (en) | Treatment of depression and pharmaceutical preparations therefor | |
| UA30011A (uk) | Спосіб профілактики гострих стресових уражень шлунково-кишкового тракту після порожнинних оперативних втручань | |
| TR199902305T2 (xx) | Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar. | |
| GEP20002141B (en) | Use of 2-Phenyl-1, 2-Benzisoselenazol-3(2H)-One for Prevention and/or Treatment of Dementia, a Pharmaceutical Composition for Prevention and/or Treatment of the Alzheimer’s Disease | |
| UA36576A (uk) | Спосіб корекції реактивності організму у хворих на інфаркт міокарда в гострому та підгострому періодах |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 851762 Country of ref document: ES |